Clinical trial
Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue…
NCT00217607 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00217607 |
|---|---|
| Title | Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery |
| Official title | Multicentric Phase II Study Evaluating the Efficacy and Toxicity of Weekly Paclitaxel in Locally Advanced or Metastatic Soft Tissue Angiosarcomas That Cannot be Treated by Surgery |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | paclitaxel |
| Enrollment | 30 |
| Start date | Feb 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Jan 1, 2012 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 30, 2016 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: